OmniaSecure MRI SureScan Lead Model 3930M
Medtronic, Inc. · Decision date Apr 24, 2026
What did the FDA decide?
FDA records P240036/S005 as a supplement to PMA P240036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 24, 2026.
FDA approval order statement
removing a redundant inspection and manufacturing tolerance changes for lead over-molded connector assemblies
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 24, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P240036/S005
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NVY
- Decision code
- OK30
- Decision date
- Apr 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Permanent defibrillator electrodes.
- Applicant
- Medtronic, Inc.
- Product code
- NVY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240036 · Original PMA
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S002 · Related supplement
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S003 · Related supplement
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S004 · Related supplement
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S005 received
Application receipt date recorded by FDA.
P240036/S006 · Related supplement
OmniaSecure MRI SureScan Lead Model 3930M
P240036/S005 · FDA decision
30-Day Notice
P240036/S007 · Related supplement
OmniaSecure MRI SureScan Lead Model 3930M
Timeline entries are records held by MedtechLedger for P240036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Apr 22, 2025 | FDA | |
OmniaSecure MRI SureScan Lead Model 3930MP240036/S002 | Medtronic, Inc. | PMA supplement | Oct 29, 2025 | FDA |
OmniaSecure MRI SureScan Lead Model 3930MP240036/S003 | Medtronic, Inc. | PMA supplement | Oct 30, 2025 | FDA |
OmniaSecure MRI SureScan Lead Model 3930MP240036/S004 | Medtronic, Inc. | PMA supplement | Mar 9, 2026 | FDA |
OmniaSecure MRI SureScan Lead Model 3930MP240036/S006 | Medtronic, Inc. | PMA supplement | Apr 24, 2026 | FDA |
OmniaSecure MRI SureScan Lead Model 3930MP240036/S007 | Medtronic, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Explore the linked device profile
Other records with product code NVY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC(R) TRANSVENE LEAD SYSTEMP920015/S307 | Medtronic, Inc. | PMA supplement | Aug 19, 2026 | FDA |
Sprint Quattro Lead (6946M)P920015/S306 | Medtronic, Inc. | PMA supplement | Jun 24, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Apr 15, 2026 | FDA | |
HV Splitter/ Adaptor kitP920015/S304 | Medtronic, Inc. | PMA supplement | Mar 6, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Feb 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P240036/S005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





